Sustained drug delivery implant
Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine free base to facilitate the release of the brimonidine free base into an eye with the polymer matrix lasts a period of time of not more than twice the drug release durat...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
21.02.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine free base to facilitate the release of the brimonidine free base into an eye with the polymer matrix lasts a period of time of not more than twice the drug release duration, but more than the drug release duration. |
---|---|
Bibliography: | Application Number: AU20140216112 |